AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Dec 04 2020
News
Pelosi On Why She Will Accept A Smaller Relief Bill: It’s ‘Okay Now Because We Have A New President’
Democrat House Speaker Nancy Pelosi said on Friday that she would work with Senate Majority Leader Mitch McConnell to pass a smaller coronavirus relief package which she deemed was now okay “because we have a new president.”
“What shifted in your opinion when the Problem Solvers Caucus had a much larger bill a few months ago?” a reporter asked Pelosi. “You did not like that piece of
The Daily WireJul 31 2021
News
FDA Extends Shelf Life of Johnson & Johnson’s COVID-19 Vaccine
The Food and Drug Administration (FDA) has agreed to extend the shelf life on Johnson & Johnson’s single-shot COVID-19 vaccine from four-and-a-half months to six months.
In a July 28 concurrence letter (pdf), the FDA said Johnson & Johnson had provided sufficient data to support the extension of the company’s vaccine to six months, including for already expired batches, provided
The Epoch TimesSep 28 2021
News
Biden, McConnell Get Booster Shots Following New CDC Guidance
President Joe Biden, 78, received a booster shot against COVID-19 at the White House on Monday afternoon, days after the Centers for Disease Control (CDC) recommended that seniors who had gotten the Pfizer-BioNTech vaccine more than six months ago should get them.
Biden’s booster dose comes after the CDC endorsed Pfizer booster shots for those 65 and over and those in long-term care,
The Daily WireSep 25 2021
Opinion
US boosters or vaccinate the world?
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) this week shared recommendations for COVID-19 vaccine booster shots, which — alongside mandates to boost vaccination rates — will help get the pandemic back under control as the second COVID-19 winter looms.
These recommendations — and the underlying evidence of vaccine effectiveness and
The HillNov 19 2020
Analysis
We may have to accept a ‘good enough’ COVID-19 vaccine, at least in 2021
Australian health minister Greg Hunt said recently the government is on track to deliver COVID-19 vaccines from March 2021.
US biotech firm Moderna has just announced its COVID-19 vaccine has 95% efficacy, following on the heels of Pfizer’s claimed 90% efficacy and the Russian Sputnik V vaccine’s 92% efficacy, albeit based on limited data and yet to be peer-reviewed.
We’ll likely
Multiple Writers - CenterApr 27 2021
News
Americans' Failure to Get 2nd COVID Shot Shows Need for 1-Dose Vaccine
The former acting director for the Centers for Disease Control and Prevention said that people are not getting their second dose of COVID-19 vaccines which “points to the importance of one-shot vaccine.” Statistics show that over 8% of people are not returning for that second, vital dose of the Pfizer or Moderna COVID-19 vaccines, according to a report in The New York Times this weekend. That
Newsmax (News)Mar 02 2021
News
Biden promises vaccine supply for all US adults by end of May
The United States will have enough coronavirus vaccine doses for every adult in the country by the end of May, President Joe Biden announced on Tuesday, as production of a third vaccine is set to ramp up.
During a news conference at the White House, Biden said he had invoked a wartime production law to require pharmaceutical company Merck & Co to help produce a newly approved
Al JazeeraDec 31 2020
News
The Oxford-AstraZeneca Vaccine Approval May Be the Most Globally Important Yet
The COVID-19 vaccine developed by the University of Oxford and AstraZeneca wasn’t the first to be OK’d by regulators in the U.K.—health officials authorized the Pfizer-BioNTech jab nearly four weeks earlier. And it’s not the most effective—Stage 3 clinical trials suggest it prevents COVID-19 symptoms about 70% of the time vs. about 95% for the Pfizer vaccine and a similar one from Moderna (
Time MagazineSep 23 2021
News
FDA authorizes booster dose of Pfizer COVID-19 vaccine for people 65 and older, high-risk workers
The Food and Drug Administration on Wednesday authorized booster doses of the Pfizer-BioNTech vaccine for people 65 and older and those whose jobs put them at high risk for exposure to COVID-19.
Individuals 18 and up who are at high risk for severe COVID-19 were also included in the authorization, which only covers those who are at least six months out from their second dose of the
USA TODAYMay 10 2021
News
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for younger teens, moving US 'closer to returning to a sense of normalcy'
A COVID-19 vaccine made by Pfizer and its German partner, BioNTech, is safe and effective enough to give to younger teens, the Food and Drug Administration said Monday in authorizing its use.
The decision means adolescents ages 12 to 15 could qualify for shots as soon as Thursday, after the Wednesday meeting of an advisory committee to the Centers for Disease Control and Prevention.
USA TODAY